Status: current, Defined. Date: 31-Mar 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3055841000168110 | Praluent (alirocumab 150 mg / 1 mL) injection, 2 x 1 mL syringes (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3055851000168112 | Praluent 150 mg/mL injection, 2 x 1 mL syringes | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Praluent (alirocumab 150 mg / 1 mL) injection, 2 x 1 mL syringes (trade product pack) | Is a | trade product pack | true | Inferred relationship | Some | ||
| Praluent (alirocumab 150 mg / 1 mL) injection, 2 x 1 mL syringes (trade product pack) | Is a | alirocumab 150 mg/mL injection, 2 x 1 mL syringes | true | Inferred relationship | Some | ||
| Praluent (alirocumab 150 mg / 1 mL) injection, 2 x 1 mL syringes (trade product pack) | has TPUU | Praluent 150 mg/mL injection, syringe | true | Inferred relationship | Some | 1 | |
| Praluent (alirocumab 150 mg / 1 mL) injection, 2 x 1 mL syringes (trade product pack) | has TP | Praluent | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Praluent 150 mg/mL injection, 2 x 1 mL syringes | Is a | True | Praluent (alirocumab 150 mg / 1 mL) injection, 2 x 1 mL syringes (trade product pack) | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR